MYL up +1.51% percent right now. $MYL High is at 54.10 and

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2014 at 3:34 PM

MYL up +1.51% percent right now. $MYL High is at 54.10 and the Low 52.44 with current volume of 889,069.

Recent News posted below.

MYL Mylan Inc Recent Headline News

KaloBios (KBIO) Looks Good: Stocks Adds 11.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 8:25AM CST
KaloBios (KBIO) was a big mover last session, with shares rising over 11% on the day.
MNK: 93.09 (+2.03), IPXL: 29.00 (+0.43), KBIO: 1.93 (+0.13), MYL: 53.84 (+0.73)

Comparing America's 3 Largest Generic Drugs Companies
Joseph Cafariello - at Seeking Alpha - Fri Nov 07, 9:05AM CST

ZTS: 40.18 (-0.05), ACT: 245.77 (-0.14), MYL: 53.84 (+0.73)

Mylan Signs Strategic Alliance Agreement with Walt Disney Parks and Resorts to Enhance Access to EpiPen® (epinephrine) Auto-Injectors
PR Newswire - Fri Nov 07, 7:00AM CST
Mylan Inc. (Nasdaq: MYL) today announced it has signed a multi-year strategic alliance agreement with Walt Disney Parks and Resorts to help increase awareness of anaphylaxis, a life-threatening (severe) allergic reaction. The agreement includes updated maps in Disney's domestic theme parks and on its cruise ships as well as updated signage in the parks that highlight locations with EpiPen® (epinephrine) and EpiPen Jr® (epinephrine) Auto-Injectors. Over time, the companies also will introduce a variety of educational resources designed to increase awareness of and preparedness for severe allergic reactions.
MYL: 53.84 (+0.73)

Mylan reports market availability of generic Loestrin 24 Fe for contraception
M2 - Thu Nov 06, 7:27AM CST
Pharmaceutical company Mylan (NasdaqGS:MYL) revealed on Wednesday the introduction of its Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1 mg/0.02 mg and Ferrous Fumarate in the US with immediate effect.
MYL: 53.84 (+0.73)

Actavis Beats on Q3 Earnings, Guides Above Expectations - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Nov 05, 9:16AM CST
Actavis' (ACT) third quarter results were boosted by the Forest Labs and Warner Chilcott acquisitions.
MNK: 93.09 (+2.03), ACT: 245.77 (-0.14), MYL: 53.84 (+0.73), TEVA: 58.11 (+0.41)

Quarterly Financial Results and Upcoming Conference - Research Reports on Mylan, Aegerion, Bard, Incyte and Boston Scientific
PR Newswire - Wed Nov 05, 7:50AM CST
Today, Analysts Review released its research reports regarding Mylan Inc. (NASDAQ: MYL), Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR), C.R. Bard, Inc. (NYSE: BCR), Incyte Corporation (NASDAQ: INCY) and Boston Scientific Corporation (NYSE: BSX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7704-100free.
BSX: 13.44 (+0.20), BCR: 163.25 (+0.87), INCY: 70.70 (+1.38), MYL: 53.84 (+0.73), AEGR: 21.61 (+0.03)

Mylan Launches Generic Loestrin 24 Fe®
PR Newswire - Wed Nov 05, 6:30AM CST
Mylan Inc. (Nasdaq: MYL) today announced the U.S. launch of its Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1 mg/0.02 mg and Ferrous Fumarate, which is the generic version of Warner Chilcott's Loestrin 24 Fe®. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.(1) Mylan has begun shipping product.
MYL: 53.84 (+0.73)

Mylan Is Near All-Time High Levels But Still A Strong Buy
Kanak Kanti De - at Seeking Alpha - Mon Nov 03, 12:10PM CST

MYL: 53.84 (+0.73)

Watch for Shares of Mylan (MYL) to Approach Resistance at $53.74
Comtex SmarTrend(R) - Fri Oct 31, 12:59PM CDT
Shares of Mylan (NASDAQ:MYL) have bullishly opened above the pivot of $51.77 today and have reached the first resistance level of $53.06. Analysts will be watching for a cross of the next upside pivot targets of $53.74 and $55.71.
MYL: 53.84 (+0.73)

Teva Beats Q3 Earnings Expectations, Updates Outlook - Analyst Blog
Arpita Dutt - Zacks Investment Research - Fri Oct 31, 12:10PM CDT
Teva (TEVA) has seven U.S. launches and multiple international launches lined up for the fourth quarter.
IPXL: 29.00 (+0.43), ACT: 245.71 (-0.20), MYL: 53.84 (+0.73), TEVA: 58.11 (+0.41)

Mylan updates guidance after Q3 results
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 11:38AM CDT

MYL: 53.84 (+0.73)

Mylan Rises On Q3 Earnings Beat, Affirms Abbott Deal
at Investor's Business Daily - Fri Oct 31, 10:17AM CDT
Mylan (MYL) was up 3%, near 54, in early trading in the stock market today after the drugmaker beat Q3 estimates late Thursday. Earlier, the stock was up more than 7% at a nearly eight-month high above 56. Earnings came in on the high end of the...
ABT: 44.07 (+0.70), SHPG: 201.00 (+2.42), MYL: 53.84 (+0.73), ABBV: 63.72 (+2.22)

Mylan (MYL) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Fri Oct 31, 10:16AM CDT
The following Mylan (MYL) conference call took place on October 30, 2014, 04:30 PM ET. This is a transcript of that earnings call:
MYL: 53.84 (+0.73)

Stocks Surge At Starting Bell; Mylan, Expedia, GoPro Rocket
at Investor's Business Daily - Fri Oct 31, 9:36AM CDT
Stocks sprinted out of the starting gate Friday, with economic news, quarterly reports and international markets all adding lift. The Nasdaq staked out an early lead, up 1.2%, asMylan (MYL), Analog Devices (ADI) and Expedia (EXPE) all opened more...
AMBA: 49.03 (+1.89), GPRO: 75.37 (-3.69), EXPE: 86.11 (+1.00), ADI: 50.35 (+0.11), MYL: 53.84 (+0.73), MELI: 136.35 (+1.60)

Mylan (MYL) Highlighted As Momo Momentum Stock
at The Street - Fri Oct 31, 8:50AM CDT
Trade-Ideas LLC identified Mylan (MYL) as a momo momentum candidate
MYL: 53.84 (+0.73)

Mylan Beats, Raises Earnings Guidance; Abbott Deal on Track - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 8:00AM CDT
Mylan (MYL) reported third quarter 2014 earnings of $1.16 per share.
MNK: 93.09 (+2.03), ABT: 44.06 (+0.69), ACT: 245.71 (-0.20), MYL: 53.84 (+0.73)

Is Mylan's Lively Third Quarter the Start of Something Special?
Dan Carroll, The Motley Fool - Motley Fool - Thu Oct 30, 8:51PM CDT
The market has undergone a topsy-turvy second half of 2014; but for investors in leading generic drugmaker Mylan , the year's brought a bountiful harvest. Mylan's stock has rocketed up more than 20% year to date, with shares vaulting higher by more...
MYL: 53.84 (+0.73), TEVA: 58.11 (+0.41)

Mylan's (MYL) CEO Heather Bresch on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 8:30PM CDT

MYL: 53.84 (+0.73)

MYLAN
at Investor's Business Daily - Thu Oct 30, 6:13PM CDT
MYLAN (MYL), a drugmaker, said Q3 EPS rose 41.5% to $1.16, topping views by 2 cents, and sales grew 17.9% to $2.08 bil, beating forecasts for $2.06 bil. Shares rose 1.2% to 53.
MYL: 53.84 (+0.73)

Pfizer's Trumenba Gains Accelerated Approval in the U.S. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 5:04PM CDT
Pfizer Inc.'s (PFE) Trumenba received accelerated FDA approval for prevention of invasive disease caused by Neisseria meningitidis serogroup B in people aged 10 - 25 years.
MNK: 93.09 (+2.03), ACT: 245.71 (-0.20), PFE: 30.25 (+0.33), MYL: 53.84 (+0.73)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cracking Down on Insider Trading: Legal vs Illegal

Why the Insider Trading Line Isn't Always Clear-Cut Insider trading is one of those buzzwords that conjures up images of Wall Street shenanigans and pricey legal battles. But believe it or not, trading on insider info isn’t always a one-way ticket to a federal prison. What determines its legality often hinges on how the information was obtained and used. It's a...

Corra Group Enhances Hiring with Digital I-9 Services

The Changing Landscape of Employment Verification Employment verification is no longer a mere formality with a paper form. Now, it’s a digital jungle, where missing a deadline isn't just a slap on the wrist, but a compliance nightmare. In steps Corra Group, bringing electronic I-9 tools to the frontlines, geared to help employers juggle the mess of forms, deadlines, and...

Data Center Piping Surges With AI Cooling to $4.5B

Liquid Cooling Revolutionizes Data Center Infrastructure Gotta hand it to the tech world, when it decides to shift, it shifts hard and fast. The data center piping market isn't just keeping up—it's sprinting. The move towards liquid-cooled AI setups isn’t just a trend; it’s a defining transformation. With a projected explosion to a $4.5 billion market by 2035, you...

InfraMed Expands Team for National Healthcare Growth

InfraMed's Bold Move in Healthcare Real Estate You know, it’s not every day you see a company go all in on healthcare properties like InfraMed’s doing. With the blitz of new personnel, we're talking about a genuine push to carve out a piece of the national market. And if you've been keeping tabs, this isn't just a hunch—they've got serious momentum brewing, and the...

Carrier Drops $600M on U.S. Manufacturing Boost

A Mighty Move in Manufacturing Carrier Global Corporation's recent muscle-flexing is something rarer than a golden goose in today's market—a $600 million thrust into beefing up U.S. manufacturing and engineering. You can't help but wonder if this is overzealous optimism or a meticulously calculated power play. Clocks don't tick this loudly without good reason, of...

Fort Point Capital Sells AMS Fulfillment to Stord

Fort Point Capital's Strategic Play Just when you thought the game was getting stale, Fort Point Capital dropped a bomb: they’ve sold AMS Fulfillment to Stord. This isn't just some late-season punt; it's a calculated play from a Boston-based private equity player known for snapping up and scaling service-oriented businesses in the lower middle market. It's like...

Tune In for Post Holdings' Earnings Call this November

Crunch Time for Post Holdings: Earnings Insight Well folks, pull out your calendars because November 20 is shaping up to be a big day for those tracking Post Holdings, Inc. (NYSE:POST). If you're in the game, this upcoming conference call is your prime chance to get the scoop on how the numbers stack up for Q4 and what's brewing for fiscal year 2027. This isn't some...

French Florist Blossoms in Los Gatos This October

A New Floral Journey Blooms in Los Gatos October's shaping up to be a vibrant month for Los Gatos, as a slice of French elegance arrives courtesy of Anhelina Baftalovska. She's not just bringing flowers; she's introducing a unique blend of life passions and entrepreneurial spirit to the community. Let's dig into this delightful story of blooms and business. A Ukrainian's...

Prepare Denver Sprinkler Systems Before Winter Strikes

Colorado's Unpredictable Weather: Don't Get Caught Cold The leaves turning color might be the signal of fall, but in Colorado, the weather seems to have a mind of its own—sunny one moment, bone-chilling the next. Denver homeowners, it's time to take a hard look at your outdoor sprinkler systems. Why? Because those freezing nights can sneak up faster than you'd think and...

Fontainebleau Las Vegas is Set to Thrill Race Fans

Revving Up for the 2026 Race Weekend Fontainebleau Las Vegas is shifting into high gear to host a spectacular 2026 Race Weekend. The luxury resort on the Strip is gearing up for a whirlwind of activities and events from November 19 to 21, ensuring that race fans will find themselves knee-deep in excitement and extravagance. Expect iconic car displays, exclusive team...